-+ 0.00%
-+ 0.00%
-+ 0.00%

Climb Bio Q1 EPS $(0.20) Beats $(0.29) Estimate

Benzinga·05/07/2026 13:27:39
Listen to the news
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.29) by 31.03 percent. This is a 35.48 percent increase over losses of $(0.31) per share from the same period last year.